# A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia

> **NCT05655819** · PHASE1,PHASE2 · COMPLETED · sponsor: **David J. Cangemi** · enrollment: 12 (actual)

## Conditions studied

- Functional Dyspepsia

## Interventions

- **DRUG:** Glutamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05655819
- **Lead sponsor:** David J. Cangemi
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-16
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05655819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05655819, "A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05655819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*